Korio, Inc.

📍 Doylestown, United States🗓 Founded 2021👥 14 employees💰 Last funded Sep 2023
Software Development🌐 korioclinical.com
Website LinkedIn
Korio is the industry’s leading compliance-centric Randomization & Trial Supply Management (RTSM) platform. Reflecting decades of hands-on experience across thousands of trial designs, Korio enables once aspirational goals around feature reusability, process repeatability, system performance, and overall system quality by embedding the latest RTSM design intelligence into our solution. Our intuitive approach to RTSM setup and management through a regulatory lens ensures audit-readiness and a predictable GxP compliant outcome on every clinical trial.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Korio, Inc.?
Korio, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Korio, Inc. last raise funding?
The most recent investment in Korio, Inc. recorded on gritt.io was in September 2023.
When was Korio, Inc. founded?
Korio, Inc. was founded in 2021.
What industry is Korio, Inc. in?
Korio, Inc. operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Korio, Inc. based?
Korio, Inc. is headquartered in Doylestown, United States.